» Articles » PMID: 23325240

Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer's-like Tauopathy

Overview
Journal J Neurosci
Specialty Neurology
Date 2013 Jan 18
PMID 23325240
Citations 377
Authors
Affiliations
Soon will be listed here.
Abstract

Tauopathies, including Alzheimer's disease (AD) and frontotemporal lobar degeneration with tau pathologies, are neurodegenerative diseases characterized by neurofibrillary tangles (NFTs) comprising filamentous tau protein. Although emerging evidence suggests that tau pathology may be transmitted, we demonstrate here that synthetic tau fibrils are sufficient to transmit tau inclusions in a mouse model. Specifically, intracerebral inoculation of young PS19 mice overexpressing mutant human tau (P301S) with synthetic preformed fibrils (pffs) assembled from recombinant full-length tau or truncated tau containing four microtubule binding repeats resulted in rapid induction of NFT-like inclusions that propagated from injected sites to connected brain regions in a time-dependent manner. Interestingly, injection of tau pffs into either hippocampus or striatum together with overlaying cortex gave rise to distinct pattern of spreading. Moreover, unlike tau pathology that spontaneously develops in old PS19 mice, the pff-induced tau inclusions more closely resembled AD NFTs because they were Thioflavin S positive, acetylated, and more resistant to proteinase K digestion. Together, our study demonstrates that synthetic tau pffs alone are capable of inducing authentic NFT-like tau aggregates and initiating spreading of tau pathology in a tauopathy mouse model.

Citing Articles

Noninvasive Detection of Oxidative Stress in a Mouse Model of 4R Tauopathy via Positron Emission Tomography with [F]ROStrace.

Gallagher E, Li S, Lee H, Xu H, Lee V, Mach R Int J Mol Sci. 2025; 26(5).

PMID: 40076472 PMC: 11899037. DOI: 10.3390/ijms26051845.


Limitations and Applications of Rodent Models in Tauopathy and Synucleinopathy Research.

Szegvari E, Holec S, Woerman A J Neurochem. 2025; 169(3):e70021.

PMID: 40026260 PMC: 11874209. DOI: 10.1111/jnc.70021.


Inducing aggresome and stable tau aggregation in Neuro2a cells with an optogenetic tool.

Sakuragi S, Uchida T, Kato N, Zhao B, Takahashi T, Hattori A Biophys Physicobiol. 2025; 21(4):e210023.

PMID: 39963597 PMC: 11832247. DOI: 10.2142/biophysico.bppb-v21.0023.


Searching for the cellular underpinnings of the selective vulnerability to tauopathic insults in Alzheimer's disease.

Torok J, Maia P, Anand C, Raj A Commun Biol. 2025; 8(1):195.

PMID: 39920421 PMC: 11806020. DOI: 10.1038/s42003-025-07575-1.


A whole-brain functional connectivity model of Alzheimer's disease pathology.

Prakash R, McKenna M, Gbadeyan O, Shankar A, Pugh E, Teng J Alzheimers Dement. 2024; 21(1):e14349.

PMID: 39711458 PMC: 11781256. DOI: 10.1002/alz.14349.


References
1.
Frost B, Jacks R, Diamond M . Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem. 2009; 284(19):12845-52. PMC: 2676015. DOI: 10.1074/jbc.M808759200. View

2.
Lee V, Brunden K, Hutton M, Trojanowski J . Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets. Cold Spring Harb Perspect Med. 2012; 1(1):a006437. PMC: 3234455. DOI: 10.1101/cshperspect.a006437. View

3.
Liu L, Drouet V, Wu J, Witter M, Small S, Clelland C . Trans-synaptic spread of tau pathology in vivo. PLoS One. 2012; 7(2):e31302. PMC: 3270029. DOI: 10.1371/journal.pone.0031302. View

4.
Aston-Jones G, Ennis M, Pieribone V, Nickell W, Shipley M . The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network. Science. 1986; 234(4777):734-7. DOI: 10.1126/science.3775363. View

5.
Guo J, Lee V . Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem. 2011; 286(17):15317-31. PMC: 3083182. DOI: 10.1074/jbc.M110.209296. View